Status:
COMPLETED
Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis
Lead Sponsor:
University Hospital, Tours
Conditions:
Rheumatoid Arthritis
Gout
Eligibility:
All Genders
18+ years
Brief Summary
First, this study will evaluate, in vitro, the cellular composition of the synovial fluid from patient with rheumatoid arthritis, gout or osteoarthritis. Then samples will be test with a new format o...
Detailed Description
Rheumatoid arthritis (RA) is one of the most common autoimmune disease in adult. It exists several drugs but none target dendritic cells even if it seems they play a major role in the physiopathology....
Eligibility Criteria
Inclusion
- Male or female over 18 years old
- Proven and possible RA or Gout or osteoarthritis
- Arthritis accessible to a puncture
- Necessary puncture for diagnosis or therapeutic
Exclusion
- Microcrystalline rheumatism other than Gout
- Known SpA
- Septic arthritis
- Biomedicament treatment
- Patient having objected to the processing of his data
Key Trial Info
Start Date :
December 13 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 8 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03416543
Start Date
December 13 2017
End Date
December 8 2021
Last Update
December 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheumatology Department, University Hospital, Tours
Tours, France, 37044